N Verses Capital, LLC Organogenesis Holdings Inc. Transaction History
N Verses Capital, LLC
- $167 Billion
- Q2 2024
A detailed history of N Verses Capital, LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 5,700 shares of ORGO stock, worth $16,017. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,700Holding current value
$16,017% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ORGO
# of Institutions
120Shares Held
62.3MCall Options Held
28.8KPut Options Held
27.9K-
Morgan Stanley New York, NY11.6MShares$32.5 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT11.5MShares$32.4 Million3.27% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$14.3 Million0.0% of portfolio
-
Assenagon Asset Management S.A.3.98MShares$11.2 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$10 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $368M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...